Skip to content

Clinical trials

Phase 3 Major Depressive Disorder trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Major Depressive Disorder Phase: Phase 3 Country / region: South Korea Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20083
20102
20111
20131
20141
20151
20163
20171
20191
20202
20211
20222
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Terminated4
Recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
H. Lundbeck A/S4
Janssen Research & Development, LLC4
Eli Lilly and Company3
Sanofi2
Takeda2
AstraZeneca1
Gangnam Severance Hospital1
GlaxoSmithKline1
Intra-Cellular Therapies, Inc.1
Janssen-Cilag International NV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Major Depressive Disorder25
Depressive Disorder5
Mood Disorders5
Mental Disorders2
Anhedonia1
Dysthymic Disorder1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.